key: cord-0865525-3pmhrc6a
authors: nan
title: P1‐78: Descriptive analysis of patients attending an outpatient post COVID‐19 clinic in a tertiary care hospital in Sri Lanka
date: 2021-11-19
journal: Respirology
DOI: 10.1111/resp.14150_78
sha: 55c75cc9d41f3c374493b20f4d3f30465d4c674e
doc_id: 865525
cord_uid: 3pmhrc6a

nan

Purpose: It has been reported that patients suffering from COVID-19 develop various physical sequelae even 2 months after the onset. This time, we investigated the effect of hospitalization for COVID-19 pneumonia on clinical symptoms after discharge. Method: Among those admitted to our hospital due to COVID-19 pneumonia, consent for clinical research was obtained. 36 cases, face-to-face medical examination 3 months after discharge, physical examination, imaging test, respiratory function test The COVID-19 sequelae were evaluated by examining, blood tests, and the presence or absence of subjective symptoms using a questionnaire. Results: The average length of stay was 22 days AE 9.5 days, COVID-19 moderate I 26 cases, moderate II 11 cases, and severe 1 case. The average age was 64 years old, and the male-female ratio was 25:13, which was a large proportion of males. According to the questionnaire, muscle weakness was the most common in 22 cases (61%), dyspnea in 14 cases (39%), thinking ability in 12 cases (33%), sputum in 12 cases (33%), and fatigue 10 cases. Of the cases (28%), 81% had some symptoms. The frequency of these symptoms did not depend on the length of hospital stay, and there was no significant difference between the two groups, mild / moderate I and moderate II / severe. Discussion: COVID-19 pneumonia was found to have various symptoms due to sequelae even 3 months after discharge. In addition, since clinical symptoms were observed regardless of the length of hospital stay and severity, it was considered to be related to individual patient factors such as underlying diseases and inadequate immune response in addition to pneumonia. Also. In particular, the frequency of muscle weakness was high, suggesting that face-to-face rehabilitation could not be performed under the COVID-19 epidemic. Background and Aims: COVID-19 is a novel epidemic which causes significant morbidity and mortality. The health effects are not limited only to the active phase of the disease. Many patients have complained of a multitude of symptoms during convalescent period as well. 1 As there is a lack of precise local data of demographic and geographic variability, we wanted to analyze these in a local setting. Methods: Ongoing prospective cohort study being conducted in an Outpatient Post COVID Clinic. Consecutive symptomatic adult patients attending this clinic from 1st May 2021 to 30th June 2021 were enrolled. This study did not require ethical approval as data are properly anonymized and informed verbal consent was obtained at the time of data collection. Results: Out of 50 total participants, 14 (28%) were males. 44 (88%) had a close contact with a confirmed case of COVID-19. 29 (58%) were Health Care Workers. Commonest symptoms were Exertional Dyspnoea (86%): [55.8% mMRC 1, 44% mMRC 2], Body Aches (46%), Chest Pain (44%), Reduced Appetite (34%), Cough (32%), Fatigue (30%), Headache (28%), Anosmia (22%), Fever (18%), Sore Throat (16%), Dizziness/Syncope (12%) and Insomnia (2%). Main comorbidities were Obesity (44%), Bronchial Asthma (22%), Dyslipidemia (22%), Hypertension (20%), Diabetes Mellitus (12%), Ischaemic Heart Disease (4%), TB (4%) and Chronic Lung Diseases (2%). Conclusion: Majority (88%) had a close contact with an identified COVID-19 case and 58% were Health Care Workers. Associated main co-morbidities were Obesity and Bronchial Asthma. Varying debilitating physical complaints were identified during this period. Thus, streamlining treatment protocols at post COVID clinics is our utmost goal.

Follow-up of adults with non-critical COVID-19 two months after symptoms' onset